| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Meetings and Conferences |
|
|
| |
| |
| |
October 18, 2004 |
|
|
| |
|
|
| |
|
|
|
IBC Life Sciences, The Boston Park Plaza Hotel & Towers, Boston, MA
January 24-25, 2005
By attending IBC’s Adaptive Designs for Clinical Development conference, you will gain a clear understanding of the strategies and methods currently under scrutiny in the clinical design community: how to balance individual and collective ethics in clinical trials; using early endpoints as auxiliary variables to enable earlier and better decisions; implementing Phase II/Phase III combined trials to determine sample size; understanding the similarities and differences between the frequentist and bayesian methods; learning the benefits of using data monitoring committees (DMCs); utilizing interim evaluation for proof of concept trials; and treating patients in trials more effectively. To register or view full conference details, visit www.IBCLifeSciences.com/3059.
|
|
|
|
|
|
|
|
Organized by:
|
|
IBC Life Sciences |
|
|
Invited Speakers:
|
|
-
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
-
|
|
|
|
|
|
|
|
Registration:
|
|
Phone: 508-616-5550 x1004
Fax: 508-616-5522
Email: reg@ibcusa.com
Mail:
IBC Life Sciences
One Research Drive
Suite 400A
Westborough, MA 01581-5195
|
|
|
E-mail:
|
|
reg@ibcusa.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|